LAS VEGAS, Jan. 5, 2017 /PRNewswire/ -- Consumers will now be able to learn exactly how their genes impact their behavioral and developmental tendencies of children. Today, ORIG3N, a leader in regenerative medicine technology and consumer genetics assessments, unveiled BLISS™ and BLOOM™, two new DNA tests focused exclusively on individuals' future development.
Introduced at the Consumer Electronics Show in Las Vegas, BLISS™ and BLOOM™ are designed to reveal genetic information that will remove some of the roadblocks along the path to optimal health. This will alleviate the frustration consumers often feel when identifying what will work best for their unique sensitivities, behavioral factors and more.
BLISS™ and BLOOM™ are the newest members of the LIFEPROFILE™ suite of genetic tests, which identify how genes impact specific areas of one's body, providing insights into consumers' genetic makeup.
"There are several types of behavioral and developmental genes – from your likelihood to experience euphoria, to your probability to be a warrior or worrier and how you can develop your potential in music, math or fitness," said Robin Smith, co-founder and CEO of ORIG3N. "Once you understand your genetic makeup, you can make choices to change your lifestyle in a way that's tailor-made for how your body works."
BLISS™ assesses the genes that impact your behavior in the following areas:
BLOOM™ assesses the genes that impact childhood development in the following areas:
Other LIFEPROFILE™ tests include FITCODE™, AURA™ skin and SUPERHERO™ assessments.
All LIFEPROFILE™ products are delivered via a mobile app exclusively on the Apple app store. For more information on ordering, please visit: http://www.orig3n.com/lifeprofile/.
Disclaimer: These products are not a diagnostic test and cannot predict your future health. All data, text, images, and graphics associated with this product are for informational purposes only. Use of this product is not intended to be a substitute for professional medical judgment. Please consult your doctor if you have a question about a medical issue.
About ORIG3N, Inc.
ORIG3N is advancing the future of medicine through genetics and regenerative medicine research. The company is doing so by engaging directly with consumers and giving consumers the opportunity to understand their genetic makeup while building the world's largest crowdsourced library of blood samples to support induced pluripotent stem cell research. The cell repository, called LIFECAPSULE™, is used to better understand the cellular and molecular foundations of genetically inherited disease. Thousands of people have already contributed to advancing the future of medicine and human genome research. The founders are serial entrepreneurs whose previous venture, ArtusLabs, was acquired by PerkinElmer in 2011.
For more information, visit www.orig3n.com.
Media Contact:
Kelsey Thompson
Kelsey.thompson@havas.com
412-855-5332
SOURCE ORIG3N